Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -62.08 | 40.66 |
PEG Ratio (TTM) | -0.85 | 5.42 |
P/S Ratio (TTM) | 1.43 | 6.33 |
P/B Ratio (TTM) | 2.20 | 5.87 |
P/FCF Ratio (TTM) | N/A | 37.81 |
Price to 5YR AVG Earnings Ratio | 189.54 | 59.41 |
Price to 5YR AVG FCF Ratio | 34.19 | 36.98 |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.43% | 4.66% |
ROE (TTM) | -3.50% | 25.49% |
Net Profit Margin (TTM) | -2.32% | 7.22% |
ROIC 5YR AVG | 3.93% | 6.54% |
Growth (13%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -626.70% | -11.36% | -67.07% |
Revenue | 0.70% | -1.47% | 0.29% |
Net Income | -637.46% | -13.22% | -66.57% |
Cash Flow | N/A | 3.16% | 246.71% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.16 | 2.64 |
Quick Ratio (TTM) | 0.74 | 1.97 |
D/E Ratio (TTM) | 0.70 | 0.55 |
Interest Coverage (TTM) | 0.77 | 2.38 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 1.86 | 7.18 |
LTL to 5YR AVG FCF | 8.22 | 3.69 |
Shares Outstanding Growth 5YR AVG | -0.41% | 1.65% |